Applied Therapeutics, Inc. (APLT)
Feb 3, 2026 - APLT was delisted (reason: acquired by Cycle Pharmaceuticals)
0.1030
0.00 (0.00%)
Inactive · Last trade price on Feb 2, 2026

Applied Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
11.9579.449.916.6653.8957.47
Short-Term Investments
---13.9226.9439.36
Cash & Short-Term Investments
11.9579.449.930.5880.8296.83
Cash Growth
-87.92%59.12%63.17%-62.16%-16.53%149.21%
Other Current Assets
19.714.254.496.737.575.76
Total Current Assets
31.6583.6554.3937.3188.39102.59
Net Property, Plant & Equipment
2.472.790.450.861.31.71
Other Long-Term Assets
0.250.25-0.20.20.2
Total Assets
34.3786.6954.8338.3689.89104.51
Accounts Payable
4.84.431.744.539.460.64
Accrued Expenses
23.4916.1415.2914.7616.5620.19
Current Portion of Leases
0.470.410.430.480.440.41
Other Current Liabilities
4.146.3153.7313.66--
Total Current Liabilities
32.927.371.1833.4226.4621.24
Long-Term Leases
2.032.390.040.410.891.33
Other Long-Term Liabilities
--0.760.46--
Total Long-Term Liabilities
2.032.390.80.880.891.33
Total Liabilities
34.9429.6971.9834.327.3522.57
Common Stock
0.040.040.010.0100
Additional Paid-in Capital
635.76631.18451.43352.83328.96242.78
Accumulated Other Comprehensive Income
---0.05-0.11-0.11
Retained Earnings
-636.36-574.21-468.59-348.82-266.32-160.73
Shareholders' Equity
-0.5657.01-17.154.0662.5481.94
Total Liabilities & Equity
34.3786.6954.8338.3689.89104.51
Total Debt
2.52.80.470.891.331.74
Net Cash (Debt)
9.4576.649.4329.6979.4995.09
Net Cash Growth
-87.67%54.97%66.50%-62.65%-16.41%158.29%
Net Cash Per Share
0.070.550.590.793.104.33
Book Value
-0.5657.01-17.154.0662.5481.94
Book Value Per Share
-0.000.41-0.200.112.443.73
Tangible Book Value
-0.5657.01-17.154.0662.5481.94
Tangible Book Value Per Share
-0.000.41-0.200.112.443.73
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q